{"id":"https://openalex.org/W3097328342","doi":"https://doi.org/10.1002/cpt.2066","title":"Model Informed Drug Development: Collaboration Through A Common Framework","display_name":"Model Informed Drug Development: Collaboration Through A Common Framework","publication_year":2020,"publication_date":"2020-10-28","ids":{"openalex":"https://openalex.org/W3097328342","doi":"https://doi.org/10.1002/cpt.2066","mag":"3097328342","pmid":"https://pubmed.ncbi.nlm.nih.gov/33111309","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8596610"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.2066","doi":"https://doi.org/10.1002/cpt.2066","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2066","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2066","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2066","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049177702","display_name":"Richard Anziano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard J. Anziano","raw_affiliation_strings":["Pharmetheus Inc., Killingworth, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmetheus Inc., Killingworth, Connecticut, USA","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108630654","display_name":"Peter A. Milligan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter A. Milligan","raw_affiliation_strings":["Pharmetheus AB, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmetheus AB, Uppsala, Sweden","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5049177702"],"corresponding_institution_ids":["https://openalex.org/I4405259476"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":0.8223,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.74264468,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"110","issue":"5","first_page":"1165","last_page":"1167"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8676999807357788,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8676999807357788,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.1200999990105629,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/model-informed-drug-development","display_name":"model-informed drug development","score":0.9810000061988831},{"id":"https://openalex.org/keywords/evidence-synthesis","display_name":"evidence synthesis","score":0.6700000166893005},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.5},{"id":"https://openalex.org/keywords/phase-iii-trial-failure","display_name":"phase III trial failure","score":0.4869999885559082},{"id":"https://openalex.org/keywords/dose-finding-trials","display_name":"dose-finding trials","score":0.6399999856948853},{"id":"https://openalex.org/keywords/confirmatory-trials","display_name":"confirmatory trials","score":0.7179999947547913},{"id":"https://openalex.org/keywords/information-maximization","display_name":"information maximization","score":0.5230000019073486},{"id":"https://openalex.org/keywords/uncertainty-reduction","display_name":"uncertainty reduction","score":0.871999979019165},{"id":"https://openalex.org/keywords/pharmaceutical-decision-making","display_name":"pharmaceutical decision-making","score":0.44699999690055847},{"id":"https://openalex.org/keywords/regulatory-decision-making","display_name":"regulatory decision-making","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.647627592086792},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48452967405319214},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3845340311527252},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.36833426356315613},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.32991352677345276},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30458784103393555},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.18697494268417358}],"mesh":[{"descriptor_ui":"D000070516","descriptor_name":"Intersectoral Collaboration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/cpt.2066","doi":"https://doi.org/10.1002/cpt.2066","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2066","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2066","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:33111309","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33111309","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8596610","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8596610/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/cpt.2066","doi":"https://doi.org/10.1002/cpt.2066","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2066","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2066","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3097328342.pdf","grobid_xml":"https://content.openalex.org/works/W3097328342.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W1975404751","https://openalex.org/W2040624495","https://openalex.org/W2547330766","https://openalex.org/W2757758976"],"related_works":["https://openalex.org/W7157901156","https://openalex.org/W2906252243","https://openalex.org/W4408884679","https://openalex.org/W7221318251","https://openalex.org/W3194301645","https://openalex.org/W3102070603","https://openalex.org/W4415227195","https://openalex.org/W7169874985","https://openalex.org/W2181278642","https://openalex.org/W4408720051"],"abstract_inverted_index":{"Model-informed":[0],"drug":[1,187,986],"development":[2,482,526,987],"(MIDD)":[3],"utilizes":[4],"the":[5,13,19,28,45,76,102,143,146,163,171,183,199,210,216,310,339,355,401,411,428,433,450,460,481,490,519,523,558,578,599,626,638,656,666,669,692,714,727,731,735,746,770,797,808,824,841,860,884,899,912,922,935,945,960,973,979,1022,1060],"knowledge":[6,242,261,662],"extracted":[7],"from":[8,512,615,644,720,951,963],"relevant":[9,193],"data":[10,513],"to":[11,71,97,120,137,166,176,190,198,243,267,330,335,362,379,413,439,443,474,508,517,556,563,576,630,636,654,725,744,768,789,839,868,874,897,918,942,968,976,1024],"improve":[12],"efficiency":[14,134],"of":[15,49,61,114,124,145,185,212,259,304,312,352,354,357,403,449,453,472,549,581,591,604,612,621,625,658,705,748,756,772,776,799,862,947,1049,1074],"decision":[16,225,429,434,483],"making":[17,430,1033],"within":[18,566,852],"pharmaceutical":[20,913],"industry.":[21],"The":[22,59,205,328,385,485,547,589,741,905,1069],"MIDD":[23,40,70,536,559,616,632,780,800,828,902,978],"framework":[24],"creates":[25,463],"overlap":[26],"between":[27,539,585,707,730],"quantitative":[29,451,850],"disciplines,":[30],"including":[31,392],"statistics":[32],"and":[33,47,51,141,203,276,294,320,360,382,432,462,478,492,515,528,533,541,561,571,583,587,596,641,649,660,694,709,738,778,812,846,854,876,889,915,966,1011,1031,1045],"pharmacometrics,":[34],"with":[35,84,181,301,407,702],"many":[36,425,520,554,569,579,728,792,909],"opportunities":[37,464],"for":[38,69,238,241,251,273,465,525,553,810,911,934,1042,1055,1066,1076],"collaboration.":[39],"necessitates":[41,537],"effective":[42,138],"alignment":[43],"in":[44,67,427,522,598,734,982,1026],"thoughts":[46],"deeds":[48],"statisticians":[50,491,540,586,708],"pharmacometricians,":[52,1010],"which":[53],"is":[54,135,159,169,173,264,387,423,488,686],"not":[55,77,93,160,687,698,802,1038],"a":[56,87,104,186,248,260,291,302,317,363,408,446,469,609,619,753,782,787,813,820,952,983,996,1027],"sector":[57],"norm.":[58],"challenge":[60,532],"greater":[62,470],"collaboration":[63,538,582,706,811],"must":[64,1014],"be":[65,149,247,326,336,506,932,940,969,1040,1053],"met":[66],"order":[68],"realize":[72],"its":[73],"potential.":[74],"In":[75],"so":[78,700,803,920],"distant":[79],"past,":[80],"trials":[81,98,117,255,300,324],"were":[82,760],"performed":[83],"an":[85,223,534,674,958],"assumed":[86],"priori":[88,105],"treatment":[89,106],"effect":[90],"that":[91,112,131,142,162,195,233,270,308,343,368,424,467,592,677,683,759,796,826,836,926,944],"was":[92,594,633,713,743,1064],"borne":[94],"out,":[95],"leading":[96],"being":[99,188,502],"repeated":[100],"(assuming":[101],"same":[103],"effect).":[107],"Harrison":[108],"et":[109,601,718],"al.1":[110],"reported":[111],"55%":[113],"phase":[115,298],"III":[116,299],"failed":[118],"due":[119],"inadequate":[121],"efficacy.":[122],"Both":[123],"these":[125,647,1003],"conditions":[126],"are":[127,179,196,271,395,437,494,500,886,891,990],"unsatisfactory.":[128],"We":[129,231,341,574,681,794,834,856,924],"contend":[130,232,342],"program":[132],"design":[133,268,671],"linked":[136],"evidence":[139,153,314,950],"synthesis":[140],"risk":[144,245],"above":[147],"can":[148,505],"mitigated":[150],"by":[151,285,716,837,994,1019],"appropriate":[152],"synthesis.":[154],"A":[155,531],"drug's":[156],"inherent":[157],"\"horsepower\"":[158],"something":[161,170],"developers":[164],"get":[165],"choose,":[167],"it":[168,263,866,1034],"team":[172],"continuously":[174],"trying":[175],"estimate/predict.":[177],"Teams":[178],"challenged":[180],"determining":[182],"probability":[184],"able":[189],"deliver":[191],"clinically":[192],"outcomes":[194,359],"meaningful":[197,1029],"patient,":[200],"prescriber,":[201],"regulator,":[202],"formulary.":[204],"Gantt":[206,332],"chart":[207],"typically":[208],"details":[209],"range":[211,303,611],"activities":[213],"needed":[214],"(and":[215,315],"associate":[217,406],"time":[218,381,383],"taken)":[219],"before":[220],"arriving":[221],"at":[222,781],"arbitrary":[224],"point,":[226],"putative":[227],"market":[228],"launch,":[229],"etc.":[230],"rather":[234],"than":[235,895],"\"only\"":[236],"optimizing":[237,240],"speed,":[239],"defray":[244],"would":[246,325,369,939,1037,1052],"long-term":[249],"recipe":[250],"success.":[252],"Viewing":[253],"individual":[254],"as":[256,752],"building":[257],"blocks":[258],"base,":[262],"quite":[265],"natural":[266],"programs":[269],"optimized":[272],"information":[274,961],"maximization":[275],"uncertainty":[277],"minimization.":[278],"Consider":[279],"two":[280,286,296,321,544],"near":[281],"identical":[282],"assets,":[283],"developed":[284],"rival":[287],"companies.":[288,793,1008],"DinosaurRX":[289],"pursues":[290],"fast-to-market":[292],"approach":[293],"initiates":[295],"parallel":[297],"doses.":[305],"KMco":[306,334],"decides":[307],"given":[309],"state":[311],"current":[313,906],"uncertainty),":[316],"dose-finding":[318],"trial":[319,929],"subsequent":[322],"confirmatory":[323],"prudent.":[327],"\"head":[329],"head\"":[331],"shows":[333],"well":[337],"behind":[338],"competition.":[340],"presenting":[344],"nonprobability":[345],"adjusted":[346],"timelines":[347],"grossly":[348],"misrepresents":[349],"our":[350,634,679,684,848,1056],"level":[351],"understanding":[353,448,473],"likelihood":[356],"future":[358],"leads":[361],"bias":[364],"toward":[365],"selecting":[366],"options":[367],"otherwise":[370],"appear":[371],"less":[372,832],"desirable.":[373],"Why":[374],"does":[375],"this":[376,550,773,1051,1067,1077],"scenario":[377],"continue":[378,917],"play,":[380],"again?":[384],"answer":[386],"fairly":[388],"involved,":[389],"but":[390,765],"elements":[391,629,974],"how":[393],"teams":[394,527],"rewarded,":[396],"what":[397],"\"success\"":[398],"looks":[399],"like,":[400],"degree":[402],"optimism":[404],"we":[405,817,843],"new":[409],"program,":[410],"will":[412,416,844,916,931,955],"advance/succeed":[414],"etc.,":[415],"play":[417,1016],"their":[418,476,872,992,1017],"part.":[419],"One":[420,624,711],"major":[421],"contributor":[422],"involved":[426],"process,":[431],"makers":[435],"themselves,":[436],"unlikely":[438],"have":[440,468,786,801,818],"been":[441,699],"exposed":[442],"anything":[444],"beyond":[445],"fundamental":[447],"aspects":[452],"variability,":[454],"uncertainty,":[455],"or":[456,831],"probability.":[457],"This":[458,606,722,1036],"raises":[459],"stakes":[461],"those":[466],"depth":[471],"use":[475],"voices":[477],"favorably":[479],"influence":[480,791],"process.":[484],"question":[486],"though":[487],"whether":[489],"pharmacometricians":[493,542,890],"speaking":[495],"up?":[496],"If":[497],"they":[498,501],"are,":[499],"heard?":[503],"What":[504],"done":[507],"bring":[509],"derived":[510,643],"inference":[511],"\"front":[514],"center\"":[516],"navigate":[518],"forks":[521],"road":[524],"senior":[529,652,869],"leaders?":[530],"opportunity,":[535],"on":[543,901],"principal":[545],"levels:":[546],"authors":[548,771,1070],"paper":[551,603,607,685,715,723],"collaborated":[552],"years":[555],"enable":[557],"philosophy":[560],"practice":[562,903],"become":[564],"embedded":[565],"one":[567],"organization,":[568],"departments,":[570],"multiple":[572],"teams.":[573,855],"tried":[575],"exemplify":[577,845],"benefits":[580,613],"partnership":[584],"pharmacometricians.":[588,710],"fruit":[590],"labor":[593],"assembled":[595],"presented":[597],"Milligan":[600],"al.":[602,719],"2013.3":[605],"quantified":[608],"diverse":[610],"obtained":[614],"application":[617],"across":[618,1007],"variety":[620],"therapeutic":[622],"areas.":[623],"most":[627,1048],"important":[628],"embed":[631],"ability":[635],"quantify":[637],"resultant":[639],"savings":[640,648,667],"efficiencies":[642,650],"MIDD.":[645],"Quantifying":[646],"allowed":[651],"leaders":[653],"appreciate":[655],"value":[657],"up-front":[659],"ongoing":[661],"management":[663,864],"activities.":[664],"Expressing":[665],"against":[668],"typical":[670],"helped":[672],"create":[673],"organizational":[675],"pull":[676],"complemented":[678],"push.":[680],"recognize":[682,795],"new,":[688],"but,":[689],"since":[690],"2013,":[691],"statistical":[693,739],"pharmacometric":[695],"literature":[696],"has":[697,807],"replete":[701],"notable":[703],"examples":[704],"exception":[712],"Visser":[717],"2018.4":[721],"sought":[724],"highlight":[726],"similarities":[729],"approaches":[732],"documented":[733],"clinical":[736,928,953,1012],"pharmacology":[737],"literature.":[740],"outcome":[742],"take":[745],"best":[747,757],"both":[749],"worlds":[750],"forward":[751],"unified":[754],"set":[755],"practices":[758],"neither":[761],"\"mine\"":[762],"nor":[763,806],"\"yours\"":[764],"\"ours.\"":[766],"Fast-forwarding":[767],"today,":[769],"paper,":[774],"instead":[775],"enabling":[777],"influencing":[779],"single":[783],"company,":[784],"now":[785,893],"vehicle":[788],"progressively":[790],"mechanics":[798],"much":[804],"changed,":[805],"need":[809,1023],"common":[814],"language.":[815],"Perhaps":[816],"learned":[819],"bit":[821],"more":[822,830,881,894,984,1028],"about":[823],"intangibles":[825],"give":[827],"implementation":[829],"traction.":[833],"hope":[835],"continuing":[838],"\"live\"":[840],"collaboration,":[842],"augment":[847],"collective":[849],"voice":[851],"organizations":[853],"cannot":[857],"stress":[858],"enough":[859],"importance":[861],"stakeholder":[863],"when":[865,883],"comes":[867],"leaders.":[870],"Having":[871],"support":[873],"sponsor":[875],"foster":[877],"cross-discipline":[878],"collaborations":[879],"becomes":[880],"straightforward":[882],"win-wins":[885],"clear.":[887],"Statisticians":[888],"obliged,":[892],"ever,":[896],"raise":[898],"bar":[900],"levels.":[904],"pandemic":[907],"presents":[908],"challenges":[910],"industry,":[914],"do":[919],"into":[921],"future.":[923,937],"know":[925],"\"normal\"":[927],"conduct":[930],"compromised":[933],"foreseeable":[936],"It":[938],"reasonable":[941],"expect":[943],"supply":[946],"direct":[948],"empirical":[949],"setting":[954],"decrease,":[956],"necessitating":[957],"increase":[959],"yield":[962],"already":[964],"studied":[965,970],"yet":[967],"patients.":[971,1061],"All":[972],"exist":[975],"make":[977],"standard":[980],"fare":[981],"rational":[985],"context.":[988],"Regulators":[989],"playing":[991],"part":[993,1018],"creating":[995],"pull,":[997],"through":[998],"pilot":[999],"programs,5,":[1000],"6":[1001],"helping":[1002],"methods":[1004],"gain":[1005],"momentum":[1006],"Statisticians,":[1009],"pharmacologists":[1013],"also":[1015],"first":[1020],"recognizing":[1021],"collaborate":[1025],"manner,":[1030],"then":[1032],"happen.":[1035],"only":[1039],"good":[1041,1054],"companies,":[1043],"regulators,":[1044],"payors;":[1046],"perhaps":[1047],"all":[1050],"experimental":[1057],"units,":[1058],"yes,":[1059],"No":[1062],"funding":[1063],"received":[1065],"work.":[1068,1078],"declared":[1071],"no":[1072],"conflicts":[1073],"interest":[1075]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-11-09T00:00:00"}